Results 151 to 160 of about 7,028 (198)

Prompt recurrence of granuloma annulare upon Janus kinase inhibitor discontinuation. [PDF]

JAAD Case Rep
Haveric A, Zhao P, Markeson CD, Hsu S.
europepmc   +1 more source

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis. [PDF]

Front Pharmacol
Ramonda R, Lorenzin M, Carletto A, Chimenti MS, Manara M, Cozzi G, Zabotti A, Foti R, Carriero A, Hoxha A, Selmi C, Raffeiner B, Giollo A, Cauli A, Salvarani C, Atzeni F, Rossini M, Fassio A, Nava F, Paci V, Moroncini G, Buonanno S, Frediani B, Luchetti Gentiloni MM, Gentileschi S.   +24 more
europepmc   +1 more source

Evaluation of a pharmacist directed treat to target approach in patients with inflammatory bowel disease receiving upadacitinib or risankizumab. [PDF]

Crohns Colitis 360
Han J, Puangampai A, Man B, Kandah HM, Rubin DT, Choi DK.   +5 more
europepmc   +1 more source

Case Report: Successful treatment of dystrophic epidermolysis bullosa pruriginosa with upadacitinib in a patient with <i>COL7A1</i>, <i>CARD14</i>, and <i>G6PD</i> gene mutations. [PDF]

Front Med (Lausanne)
Li H, Zhang Y, Lin X, Yan T, Wu X, Zhang Z.   +5 more
europepmc   +1 more source

Off-Label Use of Upadacitinib for Treatment of Lichen Planus: A Narrative Review. [PDF]

Dermatol Pract Concept
Gregory M, Esfandiari N, Daveluy S.
europepmc   +1 more source

A multicentered retrospective cohort study comparing JAK inhibitor therapies in moderate-to-severe ulcerative colitis. [PDF]

Crohns Colitis 360
Kumar A, Baxter J, Rimmer P, Noble B, Bower J, Makki MU, Hatta A, Chikhlia A, Cheesbrough J, Disney B, Muir J, Karova M, Butterworth J, Sagar N, Al-Talib I, Nahal J, Ali N, Sagar V, Varyani F, Smith S, Bourne S, Hsu YK, Eltahir A, de Silva S, Harvey P.   +24 more
europepmc   +1 more source

Case Report: Upadacitinib treatment for Behçet's syndrome with intestinal damage. [PDF]

Front Med (Lausanne)
Yuan L, Sun Y, Yan J.
europepmc   +1 more source

Systemic allergic contact dermatitis to nickel presenting predominantly as severe hand dermatitis, successfully controlled with upadacitinib: A case report. [PDF]

SAGE Open Med Case Rep
Mirzajani P, DeKoven JG, Shamsuyarova A.
europepmc   +1 more source

Comparative effectiveness of low versus high dose upadacitinib as maintenance treatment in patients with ulcerative colitis: a real-world cohort study from the United States. [PDF]

Crohns Colitis 360
Sehgal P, Kochhar GS, Kaur H, Khataniar H, Shivashankar R, Lewis JD, Desai A.   +6 more
europepmc   +1 more source

Upadacitinib Treatment for Fulminant Cutaneous and Mucosal Lichen Planus. [PDF]

Cureus
Gulati A, Smirnov BP.
europepmc   +1 more source